Keyhole breast cancer therapy to enter trials:
This article was originally published in Clinica
Endocare is to begin trials of a system for destroying breast cancers by freezing them. The technique, which Endocare calls targeted ablation therapy, is performed using a 2mm probe which is inserted into the breast and used to freeze the cancer. The company hopes to begin the trials by summer.
You may also be interested in...
Device Week, 4 December 2020 – MedWatch Question About Third-Party Servicers Slides Under Industry's Radar
On this week’s podcast: A change made by the US FDA to its MedWatch program that asks adverse event reporters whether a third party serviced a malfunctioning medical device went unnoticed by many in industry for nearly a year. We explain why, and tell how the servicer question will be helpful for manufacturers and the agency.
The series D financing will support the expansion of Everlywell’s consumer lab testing and digital health businesses.
New guidance from the UK regulator covers distribution and deployment of Pfizer/BioNTech's COVID-19 vaccine, which will be complex because of the temperature storage requirements and the large packs in which the vaccine doses will be delivered.